GGrantIndex
Sort

64,565 grants matching drug discovery

Targeting Cellular Senescence to Extend Healthspan

$3,544,455
Nathan K Lebrasseur · Mayo Clinic Rochester · P01 · FY2024 · AG

COG NCTN Network Group Operations Center - Year 10 Administrative Supplements

$3,541,929
Douglas S. Hawkins · Public Health Institute · U10 · FY2023 · CA

CCR Office of Training and Education

$3,540,997
Jonathan Scott Wiest · Division Of Basic Sciences - Nci · ZIJ · FY2012 · CA

Kentucky Center for Clinical and Translational Science

$3,539,422
Philip A Kern · University Of Kentucky · UL1 · FY2011 · RR

Utah Trial Innovation Center

$3,539,199
Jonathan Michael Dean · University Of Utah · U24 · FY2018 · TR

DCTD Cancer Imaging

$3,537,972
David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2014 · CA

Molecular and Clinical Manifestations of Matrix and Aggregate Myopathies

$3,535,200
Carsten Bonnemann · National Institute Of Neurological Disorders And Stroke · ZIA · FY2018 · NS

Cincinnati Center for Clinical and Translational Sciences and Training

$3,534,131
James E. Heubi · University Of Cincinnati · UL1 · FY2013 · TR

DCTD Computer Support

$3,533,659
David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2018 · CA

Pharmacogenomics of Arrhythmia Therapy

$3,532,824
Dan M Roden · Vanderbilt University · U19 · FY2011 · HL

Calcineurin Mediates the Synergistic Toxicity of Tau and Aβ Oligomers

$3,532,750
Giulio Taglialatela · University Of Texas Med Br Galveston · RF1 · FY2019 · AG

Support for Enhancement Excellence in Research at UPR RP

$3,530,236
Rafael Arce Arce · University Of Puerto Rico Rio Piedras · S06 · FY2006 · GM

PET Radiopharmaceutical Sciences

$3,529,636
Victor W Pike · National Institute Of Mental Health · Z01 · FY2007 · MH

Texas A&M University Interdisciplinary Life Sciences Building Build-Out

$3,529,612
J. Martin Scholtz · Texas A&M University · C06 · FY2010 · RR

COG NCTN Year 11 BIQSFP Progress Report

$3,527,865
Douglas S. Hawkins · Public Health Institute · U10 · FY2024 · CA

Rush Alzheimer's Disease Core Center

$3,522,718
David A Bennett · Rush University Medical Center · P30 · FY2020 · AG

Development of a Long-acting Enzyme Therapy for Treatment of Cocaine Abuse

$3,521,342
Chang-Guo Zhan · University Of Kentucky · U01 · FY2021 · DA

Development of a Long-acting Enzyme Therapy for Treatment of Cocaine Abuse

$3,521,165
Chang-Guo Zhan · University Of Kentucky · U01 · FY2020 · DA

Extramural Research Facilities Improvement Program: Ren*

$3,519,397
Howard University · C06 · FY2004 · RR

Translational Research Core

$3,518,272
Colin Osborne · University Of Texas Med Br Galveston · U19 · FY2023 · AI

SEQUENCING 12 MB OF THE SCHISTOSOMA MANSONI GENOME

$3,517,891
Institute For Genomic Research · U01 · FY2002 · AI

DCTD Cancer Imaging

$3,514,967
David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2017 · CA

Towards a comprehensive signaling pathway map of parahippocampal vulnerability in Alzheimers Disease

$3,514,658
Bin Zhang · Icahn School Of Medicine At Mount Sinai · RF1 · FY2017 · AG

Penn Center for AIDS Research

$3,512,603
Ronald G Collman · University Of Pennsylvania · P30 · FY2019 · AI

Pharmacogenomics of Arrhythmia Therapy

$3,512,594
Dan M Roden · Vanderbilt University · U19 · FY2012 · HL